Skip to main content
Clinical Trials/NCT02861612
NCT02861612
Withdrawn
Not Applicable

Nerve Transfers to Restore Hand Function in Spinal Cord Injury

Ottawa Hospital Research Institute2 sites in 2 countriesAugust 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quadriplegia
Sponsor
Ottawa Hospital Research Institute
Locations
2
Primary Endpoint
Upper extremity function - Range of motion
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

This study seeks to evaluate the efficacy of nerve transfers in restoring hand function in patients with cervical spinal injuries.

Detailed Description

Cervical spinal cord injury is a life-altering injury that results in profound loss of upper limb function. Hand function is essential to basic activities of daily living and consequently has a significant impact on patients' quality of life. Tendon transfers and/or tenodesis have traditionally been used to restore hand function in spinal cord injuries - however, in recent years there is growing interest in the role of nerve transfers as a means of accomplishing this goal. Although preliminary results indicate nerve transfers may be well-suited for patients with spinal cord injury, their long term efficacy has not been demonstrated. This study seeks to evaluate the efficacy of nerve transfers in restoring hand function in patients with cervical spinal injuries. Eligible patients will receive nerve transfer procedure(s) (e.g. brachialis to anterior interosseous nerve, supinator to posterior interosseous) and will be followed post-operatively to assess for changes in strength, functional independence, and quality of life.

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
March 18, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with a spinal cord injury AIS level C5 to C
  • Those with motor complete injuries (AIS A or B) will be considered for surgical intervention if they are ≥ 5 months post injury. Motor incomplete patients (AIS C or D) will be considered if they are ≥ 1.5 years post injury.
  • Patients will require ≥ MRC 4 strength of the muscle supplied by the donor nerve (e.g. brachialis, supinator).
  • Finger flexor and extensor strength should be ≤ MRC 1 strength.
  • Muscles supplied by the donor nerve, will need to have no or minimal of evidence of lower motor neuron injury as dictated by evidence of fibrillations, positive sharp waves, or moderate or severely decreased recruitment on needle electromyography.
  • Those being evaluated for surgery outside nine-months post injury recipient muscles will be required to be free of lower motor neuron pathology.
  • Ability to comply and participate in rigorous post-surgical therapy regimen.

Exclusion Criteria

  • Comorbidities precluding safe surgery including autonomic/hemodynamic instability, pulmonary instability, active infection, chronic pressure sores or untreated urinary tract infections as determined by physician.
  • Simultaneous tendon transfer or tenodesis surgery (which would preclude separation of the effect of nerve transfer alone).

Outcomes

Primary Outcomes

Upper extremity function - Range of motion

Time Frame: Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

Quantitative assessment of range of motion (degrees)

Upper extremity function - Manual muscle testing (MRC)

Time Frame: Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

Quantitative assessment of motor function (MRC)

Upper extremity function - Graded Redefined Assessment of Strength, Sensibility and Prehension test (GRASSP)

Time Frame: Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

Valid, reliable and responsive measure of sensorimotor upper limb impairment specifically designed for patients with cervical SCI

Upper extremity function - Myometric measures of strength (donor and recipient muscle groups)

Time Frame: Change from baseline at 6, 12, 24, 30 and 36 months post-surgery

Valid and reliable quantitative muscle strength measurement

Secondary Outcomes

  • Health related quality of life - Canadian Occupational Performance Measure (COPM)(Change from baseline at 6, 12, 24, 30 and 36 months post-surgery)
  • Health related quality of life - Semi-structured interviews(Collected at 12 and 24 months post-surgery.)
  • Health related quality of life - Spinal Cord Independence Measure (SCIM I)(Change from baseline at 6, 12, 24, 30 and 36 months post-surgery)
  • Health related quality of life - The Short Form (SF)-36(Change from baseline at 6, 12, 24, 30 and 36 months post-surgery)

Study Sites (2)

Loading locations...

Similar Trials